PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Microbiology and Immunology, University of Iowa, Iowa City, Iowa, United States of America.\', \'Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center, Dallas, Texas, United States of America.\', \'Department of Biomedicine, University of Bergen, Bergen, Norway.\', \'BerGenBio ASA, Bergen, Norway.\', \'Biocenter Oulu & Faculty of Biochemistry and Molecular Medicine, University of Oulu, Oulu, Finland.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1371/journal.ppat.1009743
?:doi
?:hasPublicationType
?:journal
  • PLoS pathogens
is ?:pmid of
?:pmid
?:pmid
  • 34797899
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 4.006
?:rankingScore_hIndex
  • 154
is ?:relation_isRelatedTo_publication of
?:title
  • Phosphatidylserine receptors enhance SARS-CoV-2 infection.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34797899>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34797899>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all